ResMed

ResMed

Signal active

Investment Firm

Overview

At ResMed we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.

Highlights

Founded

1989

Industry

Health Care

Employees

10001+

Investment

7

Lead Investment

2

Exits

2

Stages

Early Stage Venture, Late Stage Venture, Seed

Investor Type

N/A

Location

United States, North America

Contact Information

Social

Profile Resume

ResMed, established in 1989 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Health Care, Medical, Health Diagnostics, Software, E-Commerce, Marketplace, Retail, Sports, Cyber Security, SaaS. The organization boasts a portfolio of 7 investments, with an average round size of $16.7M and 2 successful exits. Their recent investments include BiancaMed, Seventure Partners, Enterprise Ireland, ePlanet Capital, Noctrix Health. The highest investment round they participated in was $4.1B. Among their most notable exits are BiancaMed and Seventure Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Brett Sandercock

Brett Sandercock

Chief Financial Officer

imagePlace Peter Farrell

Peter Farrell

Founder & Chair of the board

imagePlace Brian Niznik

Brian Niznik

Head of Licensing

imagePlace Charul Vyas

Charul Vyas

Director, Strategy

imagePlace Raymond Collins

Raymond Collins

Global Leader of Data Management and Data Governance

imagePlace Andrew Huxter

Andrew Huxter

VP Northern Europe & Growth Markets EMEA

Investment portfolio

ResMed has made 7 investments. Their most recent investment was on Jan 16, 2024, when Noctrix Health raised $40.0M.

ResMed has made 3 diversity investments. Their most recent diversity investment was on Mar 31, 2022, when Candlelit Care raised $25.0K.

investments

7

Diversity investments

3

Lead investments

2

Number of exits

2

Investments

7

Annouced DateOrganization NameIndustryMoney Raised
Mar 31, 2022
Candlelit Care Candlelit Care
Artificial Intelligence (AI)25.0K
Apr 12, 2022
curie ai curie ai
Artificial Intelligence (AI)null
Jan 27, 2023
Medihive Medihive
Software7.6M
Jan 16, 2024
Noctrix Health Noctrix Health
Health Care40.0M

Exits

2

Funding Timeline

Funding rounds

7

Investors

0

Funds

0

Funding Rounds

7

ResMed has raised 7 rounds. Their latest funding was raised on Jan 16, 2024 from a Series C - Noctrix Health round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Mar 31, 2022
Non Equity Assistance - Candlelit Care Non Equity Assistance - Candlelit Care
-25.0K-
Apr 12, 2022
Seed Round - curie ai Seed Round - curie ai
-0-
Jan 27, 2023
Venture Round - Medihive Venture Round - Medihive
-7.6M-
Jan 16, 2024
Series C - Noctrix Health Series C - Noctrix Health
-40.0M-

Investors

1

Investor NameLead InvestorFunding RoundMoney Raised
-No
Post-IPO Debt - ResMed
500.0M

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.